Virax Biolabs Group Other Current Assets

The latest other current assets for VRAX is $260K as of March 2026. That compares with $540K in the prior-year period — down 51.4% year over year. Investors often review this figure alongside Virax Biolabs Group's historical trend and sector peers before judging valuation or financial health.

Over the past year, VRAX's other current assets moved from $540K to $260K — a 51.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Virax Biolabs Group's operating scale or balance-sheet position.

A other current assets figure of $260K for VRAX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting VRAX's other current assets ($260K), review year-over-year change from $540K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.